Found 16 matching trials
PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy Volunteers
PHASE1This is an open-label, parallel-group study to compare the pharmacokinetics...
Location
Avail Clinical Research
Study of IDN-6556 in Patients With Severe Alcoholic Hepatitis and Contraindications to Steroid Therapy
PHASE2The main purpose of the study is to test if taking a study drug called emri...
Location
Indiana University
Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14
N/ATo validate the ability of the Methacetin Breath Test (MBT) to detect clini...
A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases
PHASE2The purpose of this study is to determine the safety and efficacy of IDN-65...
Location
University of Miami
Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation
PHASE2The purpose of the study is to test the safety and effectiveness of IDN-655...
Location
Mayo Clinic Scottsdale
Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17
N/AThis study is a companion protocol that will use the data generated by Cona...
Location
Florida Digestive Health Specialists Research Institute
Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis
PHASE2This is a multicenter, double-blind, randomized, placebo-controlled trial i...
Location
University of Alabama at Birmingham
Caspase Inhibition in Islet Transplantation
PHASE1This is an Investigator Initiated, Phase I/II study, where Type 1 diabetic ...
Location
University of Alberta
A Study of IDN-6556 in Subjects With Liver Cirrhosis
PHASE2This is a multicenter study to see if treatment with IDN-6556 can help impr...
Location
University of Alabama at Birmingham
PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers
PHASE1This is an open-label, parallel-group study to compare the pharmacokinetics...
Location
Avail Clinical Research